Microneedles for Transdermal Drug Delivery 2019
DOI: 10.1007/978-3-030-15444-8_7
|View full text |Cite
|
Sign up to set email alerts
|

Recent Trends in Microneedle Development & Applications in Medicine and Cosmetics (2013–2018)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 324 publications
0
2
0
Order By: Relevance
“…At present, cosmeceuticals are probably one of the most tested ingredient groups in clinical trials in combination with MNA [155]. This can be attributed mainly to the ability of MNA to deposit the active ingredient in the viable epidermis and to the simpler and faster regulatory processes associated with this field in comparison with that of medicinal products.…”
Section: Cosmeceuticalsmentioning
confidence: 99%
“…At present, cosmeceuticals are probably one of the most tested ingredient groups in clinical trials in combination with MNA [155]. This can be attributed mainly to the ability of MNA to deposit the active ingredient in the viable epidermis and to the simpler and faster regulatory processes associated with this field in comparison with that of medicinal products.…”
Section: Cosmeceuticalsmentioning
confidence: 99%
“…Moreover, Dermapen ® has two operating modes: high speed (700 cycles per minute) and low speed (412 cycles per minute) [25]. Dermapen ® has benefits over Dermaroller ®, as it provides disposable needles, uniform application of pressure on the skin, and minimum risk of tips breaking in the skin [28,42]. In addition, it can treat delicate regions around the eyes, lips, and nose without damaging the skin [28].…”
Section: Microneedling Devicesmentioning
confidence: 99%